Table 1.
BLCA Serum samples | ||
---|---|---|
BLCA Patients Characteristics | ||
Ethnicity | African American (n=17; 25%) | |
European American (n=49; 74%) | ||
Unknown (n=1; 1%) | ||
Smoking status | n=26 (39%; Never smoker) | |
n=31 (46%; Former-smoker) | ||
n=10 (15%; Current smoker) | ||
Gender | n= 46(69%; Male) | |
n=21(31%; Female) | ||
Cohorts | NCI (n= 59; 88%) | |
Georgia (n =8; 12%) | ||
T-stage | Ta=1(1%) | |
T1=1(1%) | ||
T2=2(2%) | ||
T3=1(1%) | ||
T4=62(95%) | ||
Age | ≤50 years= 8(12%) | |
>50 years= 59 (88%) | ||
LVI* | LVI-Positive=59(89%) | |
LVI-Negative=8(11%) | ||
Number of packets per year | Current Smokers | |
<20Pack/year=5(50%) | ≥20Pack/year=5(50%) | |
Duration of cessation | Former Smokers | |
Quit <20years ago=9(29%) | Quit ≥20years ago=22(71%) | |
Case Control serum samples | ||
Characteristics | ||
Ethnicity | African American (n=14; 70%) | |
European American (n=3; 15%) | ||
Hispanic (n=3; 15%) | ||
Smoking status | n=9 (45%; Never smoker) | |
n=7 (35%; Former-smoker) | ||
n=4 (20%; Current smoker) | ||
Gender | n=10 (50%; Male) | |
n=10 (50%; Female) |
Lymphovascular invasion